Atrial fibrillation Trials in Vancouver, Canada
Conditions / Atrial fibrillation / Vancouver, Canada
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
45 total trials for this combination
Showing top 10 of 45 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT05963698 | The Fourth Left Atrial Appendage Occlusion Study | RECRUITING | NA |
| NCT03968393 | Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress | RECRUITING | PHASE4 |
| NCT01830543 | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | COMPLETED | PHASE3 |
| NCT01938248 | Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation | COMPLETED | PHASE4 |
| NCT02168829 | Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial | COMPLETED | PHASE4 |
| NCT04226547 | Amplatzer Amulet LAAO vs. NOAC | ACTIVE_NOT_RECRUITING | NA |
| NCT05643573 | A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke | TERMINATED | PHASE3 |
| NCT00846924 | 30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event | UNKNOWN | NA |
| NCT02964208 | AMPLATZER™ LAA Occluder Post Approval Study (PAS) | COMPLETED | — |